Bausch Health Companies Inc 2024年度报告

FORM10-K ☒ANNUAL REPORT PURSUANT TO SECTION13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 For the Fiscal Year EndedDecember 31, 2024OR ☐TRANSITION REPORT PURSUANT TO SECTION13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934For the transition period from____________to ____________ Commission File Number:001-14956 Bausch Health Companies Inc.(Exact Name of Registrant as Specified in its Charter) British Columbia,Canada98-0448205(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.) (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code(514)744-6792 Securities registered pursuant to Section12(b) of the Act: Securities registered pursuant to section12(g) of the Act: (Title of class) Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule405 of the Securities Act.YesýNoo Indicate by check mark if the registrant is not required to file reports pursuant to Section13 or Section15(d) of the Act.Yeso Noý Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or Section15(d) of the Securities ExchangeAct of 1934 during the preceding 12months (orfor such shorter period that the registrant was required to file such reports), and (2)has been subjectto such filing requirements for the past 90days.YesýNoo Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405of RegulationS-T during the preceding 12months (orfor such shorter period that the registrant was required to submit such files).YesýNoo Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, oran emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerginggrowth company” in Rule12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with anynew or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internalcontrol over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm thatprepared or issued its audit report.☒ If securities are registered pursuant to Securities Act Section 12(b), indicate by check mark whether the financial statements of the registrant includedin the filing reflect the correction of an error to previously issued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensationreceived by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ The aggregate market value of the common shares held by non-affiliates of the registrant as of the last business day of the registrant’s most recentlycompleted second fiscal quarter was $2,125,737,497based on the last reported sale price on the NewYork Stock Exchange on June30,2024. The number of outstanding shares of the registrant’s common stock as of February14, 2025 was367,933,897. DOCUMENTS INCORPORATED BY REFERENCE PartIII incorporates certain information by reference from the registrant’s proxy statement for the 2025 Annual Meeting of Shareholders. Such proxystatement will be filed no later than 120days after the close of the registrant’s fiscal year ended December31, 2024. TABLE OF CONTENTS GENERAL INFORMATION PART I Item1.Business1Item1A.Risk Factors16Item1B.Unresolved Staff Comments54Item1C.Cybersecurity55Item2.Properties56Item3.Legal Proceedings57Item4.Mine Safety Disclosures57PART IIItem5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchasesof Equity Securities58Item 6.Reserved61Item7.Management’s Discussion and Analysis of Financial Condition and Results of Operations62Item7A.Quantitative andQualitative Disclosures About Market Risk106Item8.Financial Statements and Supplementary Data106Item9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure106Item9A.Controls and Procedures106Item9B.Other Information107Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections107PART IIIItem10.Directors, Executive Officers and Corporate Governance108Item11.Executive Compensation108Item12.Security Ownership of Certain Beneficial Owners and Management and RelatedStockholder Matters108Item13.Certain Relationships and Related Transa